Upgrade

Senti Biosciences Holdings, Inc

SNTI

Last
$0.31
Day
-2.3%
1y
-83.1%
5y
-99.3%
52w
-88.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1233d
EMA 21
0.33
EMA 50
0.40
EMA 200
0.86
20d high
-13.1%
5y high
-99.6%
5y range
0th
Website · 39 employees · United States

Positions held

Your positions

SNTI isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-12
Hold
avoid
Signal
Sell
Target
$0.38
Stop
$0.28
Stop distance
10.9%
Target vs last
+20.9%

Fundamentals

Market cap$10.02MEnterprise value$23.64MTrailing P/E—Forward P/E-0.34
PEG—Price / book-2.95Beta2.22Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin-793.7%
Profit margin0.0%ROE-4.7%ROA-65.6%Debt / equity—
Current ratio0.83Free cash flow-$17.11MAnalyst recommendationnoneMean target$13.50
52w high$2.8852w low$0.29

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M—
Op margin-85229.4%-71862.5%-61745.5%———
Net income-$12.8M-$4.2M-$14.5M-$18.1M-$14.7M—
Gross margin——————
Gross profit——————
Operating income-$14.5M-$11.5M-$13.6M-$16.9M-$16.8M—
  • Revenue +6% vs prior quarter ($0.0M vs $0.0M).
  • Operating margin compressed to -85229.4%.

Yearly (6y)

20252024202320222021
Revenue$0.0M$0.0M$2.0M$3.3M—
Op margin-289668.2%—-3375.4%-1889.3%—
Net income-$61.4M-$52.8M-$71.1M-$58.2M—
Gross margin—————
Gross profit—————
Operating income-$63.7M-$60.7M-$66.8M-$62.1M—
Headline scan

Headlines — watch

• [WARN · legal] Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline

News

SNTI · daily+1.9% over 13 sessions
Close EMA21 EMA50 EMA200
0.300.320.330.350.372026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$18M-$14M-$9M-$5M$0M-85229%-42610%10%2025-Q22025-Q32025-Q42026-Q12026-Q2